miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells

European Journal of Cell Biology

Volumn 96, Issue 8, 2017, Pages 758-766

  Bartoszewski, Rafal ^a   Serocki, Marcin ^a   Janaszak Jasiecka, Anna ^a   Bartoszewska, Sylwia ^a   Kochan Jamrozy, Kinga ^a   Piotrowski, Arkadiusz ^a   Króliczewski, Jarosław ^b   Collawn, James F ^c  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

HIF 1; HIF 2; hsa miR 200b 3p; HUVEC; KLF2; Micro RNA 200b

Indexed keywords

ANTAGOMIR; COMPLEMENTARY RNA; HYPOXIA INDUCIBLE FACTOR; KRUPPEL LIKE FACTOR 2; MESSENGER RNA; MICRORNA 200B; RNA; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR ZEB1; KLF2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; MICRORNA; MIRN200 MICRORNA, HUMAN;

ALGORITHM; ANGIOGENESIS; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ISOLATION; RNA SEQUENCE; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WESTERN BLOTTING; GENETIC TRANSFECTION; GENETICS; METABOLISM;

CELL HYPOXIA; DOWN-REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; RNA, MESSENGER; TRANSFECTION;

EID: 85031327906     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2017.10.001     Document Type: Article

References (57)

1. Agarwal, V., Bell, G.W., Nam, J.W., Bartel, D.P., Predicting effective microRNA target sites in mammalian mRNAs. eLife, 2015, 4.
2. Amano, K., Matsubara, H., Iba, O., Okigaki, M., Fujiyama, S., Imada, T., Kojima, H., Nozawa, Y., Kawashima, S., Yokoyama, M., Iwasaka, T., Enhancement of ischemia-induced angiogenesis by eNOS overexpression. Hypertension 41 (2003), 156–162.
3. Anderson, K.P., Kern, C.B., Crable, S.C., Lingrel, J.B., Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Kruppel-like factor: identification of a new multigene family. Mol. Cell. Biol. 15 (1995), 5957–5965.
4. Bartoszewska, S., Kochan, K., Madanecki, P., Piotrowski, A., Ochocka, R., Collawn, J.F., Bartoszewski, R., Regulation of the unfolded protein response by microRNAs. Cell. Mol. Biol. Lett. 18 (2013), 555–578.
5. Bartoszewska, S., Kochan, K., Piotrowski, A., Kamysz, W., Ochocka, R.J., Collawn, J.F., Bartoszewski, R., The hypoxia-inducible miR-429 regulates hypoxia-inducible factor-1alpha expression in human endothelial cells through a negative feedback loop. FASEB J. 29 (2015), 1467–1479.
6. Bartoszewski, R., Brewer, J.W., Rab, A., Crossman, D.K., Bartoszewska, S., Kapoor, N., Fuller, C., Collawn, J.F., Bebok, Z., The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes. J. Biol. Chem. 286 (2011), 41862–41870.
7. Bartoszewski, R., Hering, A., Marszall, M., Stefanowicz Hajduk, J., Bartoszewska, S., Kapoor, N., Kochan, K., Ochocka, R., Mangiferin has an additive effect on the apoptotic properties of hesperidin in Cyclopia sp. tea extracts. PLoS One, 9, 2014, e92128.
8. Ben-Ari Fuchs, S., Lieder, I., Stelzer, G., Mazor, Y., Buzhor, E., Kaplan, S., Bogoch, Y., Plaschkes, I., Shitrit, A., Rappaport, N., Kohn, A., Edgar, R., Shenhav, L., Safran, M., Lancet, D., Guan-Golan, Y., Warshawsky, D., Shtrichman, R., GeneAnalytics: an integrative gene set analysis tool for next generation sequencing, RNAseq and microarray data. OMICS 20 (2016), 139–151.
9. Bergers, G., Benjamin, L.E., Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3 (2003), 401–410.
10. Betel, D., Wilson, M., Gabow, A., Marks, D.S., Sander, C., The microRNA.org resource: targets and expression. Nucleic Acids Res. 36 (2008), D149–153.
11. Betel, D., Koppal, A., Agius, P., Sander, C., Leslie, C., Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol., 11, 2010, R90.
12. Bhattacharya, R., Senbanerjee, S., Lin, Z., Mir, S., Hamik, A., Wang, P., Mukherjee, P., Mukhopadhyay, D., Jain, M.K., Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. J. Biol. Chem. 280 (2005), 28848–28851.
13. Birnbaum, D., VEGF-FLT1 receptor system: a new ligand-receptor system involved in normal and tumor angiogenesis. Jpn. J. Cancer Res.: Gann, 86, 1995 inside cover.
14. Brabletz, S., Brabletz, T., The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer?. EMBO Rep. 11 (2010), 670–677.
15. Brooks, P.C., Clark, R.A., Cheresh, D.A., Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264 (1994), 569–571.
16. Chan, Y.C., Khanna, S., Roy, S., Sen, C.K., miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J. Biol. Chem. 286 (2011), 2047–2056.
17. Chan, Y.C., Roy, S., Khanna, S., Sen, C.K., Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2. Arterioscler. Thromb. Vasc. Biol. 32 (2012), 1372–1382.
18. Chang, S.-H., Lu, Y.-C., Li, X., Hsieh, W.-Y., Xiong, Y., Ghosh, M., Evans, T., Elemento, O., Hla, T., Antagonistic function of the RNA-binding protein HuR and miR-200b in post-transcriptional regulation of vascular endothelial growth factor-A expression and angiogenesis. J. Biol. Chem. 288 (2013), 4908–4921.
19. Chen, J., Stahl, A., Krah, N.M., Seaward, M.R., Dennison, R.J., Sapieha, P., Hua, J., Hatton, C.J., Juan, A.M., Aderman, C.M., Willett, K.L., Guerin, K.I., Mammoto, A., Campbell, M., Smith, L.E., Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation 124 (2011), 1871–1881.
20. Chen, J., Wang, L., Matyunina, L.V., Hill, C.G., McDonald, J.F., Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. Gynecol. Oncol. 121 (2011), 200–205.
21. Choi, Y.C., Yoon, S., Jeong, Y., Yoon, J., Baek, K., Regulation of vascular endothelial growth factor signaling by miR-200b. Mol. Cells 32 (2011), 77–82.
22. Feinberg, M.W., Lin, Z., Fisch, S., Jain, M.K., An emerging role for Kruppel-like factors in vascular biology. Trends Cardiovasc. Med. 14 (2004), 241–246.
23. Ferrara, N., Gerber, H.P., LeCouter, J., The biology of VEGF and its receptors. Nat. Med. 9 (2003), 669–676.
24. Greco, S., Martelli, F., MicroRNAs in hypoxia response. Antioxid. Redox Signal. 21 (2014), 1164–1166.
25. Greco, S., Gaetano, C., Martelli, F., HypoxamiR regulation and function in ischemic cardiovascular diseases. Antioxid. Redox Signal. 21 (2014), 1202–1219.
26. Hashiya, N., Jo, N., Aoki, M., Matsumoto, K., Nakamura, T., Sato, Y., Ogata, N., Ogihara, T., Kaneda, Y., Morishita, R., In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade. Circulation 109 (2004), 3035–3041.
27. Janaszak-Jasiecka, A., Bartoszewska, S., Kochan, K., Piotrowski, A., Kalinowski, L., Kamysz, W., Ochocka, R.J., Bartoszewski, R., Collawn, J.F., miR-429 regulates the transition between Hypoxia-Inducible Factor (HIF)1A and HIF3A expression in human endothelial cells. Sci. Rep.-U. K., 6, 2016.
28. Kawanami, D., Mahabeleshwar, G.H., Lin, Z., Atkins, G.B., Hamik, A., Haldar, S.M., Maemura, K., Lamanna, J.C., Jain, M.K., Kruppel-like factor 2 inhibits hypoxia-inducible factor 1alpha expression and function in the endothelium. J. Biol. Chem. 284 (2009), 20522–20530.
29. Kozomara, A., Griffiths-Jones, S., miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 42 (2014), D68–73.
30. Kruger, J., Rehmsmeier, M., RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 34 (2006), W451–454.
31. Kuo, C.T., Veselits, M.L., Barton, K.P., Lu, M.M., Clendenin, C., Leiden, J.M., The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev. 11 (1997), 2996–3006.
32. Larionov, A., Krause, A., Miller, W., A standard curve based method for relative real time PCR data processing. BMC Bioinform., 6, 2005, 62.
33. Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005), 15–20.
34. Li, E.H., Huang, Q.Z., Li, G.C., Xiang, Z.Y., Zhang, X., Effects of miRNA-200b on the development of diabetic retinopathy by targeting VEGFA gene. Biosci. Rep., 37, 2017.
35. Lin, Z., Kumar, A., SenBanerjee, S., Staniszewski, K., Parmar, K., Vaughan, D.E., Gimbrone, M.A. Jr., Balasubramanian, V., Garcia-Cardena, G., Jain, M.K., Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ. Res. 96 (2005), e48–57.
36. Love, T.M., Moffett, H.F., Novina, C.D., Not miR-ly small RNAs: big potential for microRNAs in therapy. J. Allergy Clin. Immunol. 121 (2008), 309–319.
37. Madanecki, P., Kapoor, N., Bebok, Z., Ochocka, R., Collawn, J.F., Bartoszewski, R., Regulation of angiogenesis by hypoxia: the role of microRNA. Cell. Mol. Biol. Lett. 18 (2013), 47–57.
38. Malaguarnera, L., Pilastro, M.R., Quan, S., Ghattas, M.H., Yang, L., Mezentsev, A.V., Kushida, T., Abraham, N.G., Kappas, A., Significance of heme oxygenase in prolactin-mediated cell proliferation and angiogenesis in human endothelial cells. Int. J. Mol. Med. 10 (2002), 433–440.
39. Mitchell, T.S., Bradley, J., Robinson, G.S., Shima, D.T., Ng, Y.S., RGS5 expression is a quantitative measure of pericyte coverage of blood vessels. Angiogenesis 11 (2008), 141–151.
40. Roybal, J.D., Zang, Y., Ahn, Y.H., Yang, Y.N., Gibbons, D.L., Baird, B.N., Alvarez, C., Thilaganathan, N., Liu, D.D., Saintigny, P., Heymach, J.V., Creighton, C.J., Kurie, J.M., miR-200 inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol. Cancer Res. 9 (2011), 25–35.
41. Sen, B., Johnson, F.M., Regulation of SRC family kinases in human cancers. J. Signal Transduct., 2011, 2011, 865819.
42. SenBanerjee, S., Lin, Z., Atkins, G.B., Greif, D.M., Rao, R.M., Kumar, A., Feinberg, M.W., Chen, Z., Simon, D.I., Luscinskas, F.W., Michel, T.M., Gimbrone, M.A. Jr., Garcia-Cardena, G., Jain, M.K., KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J. Exp. Med. 199 (2004), 1305–1315.
43. Sinha, M., Ghatak, S., Roy, S., Sen, C.K., microRNA–200b as a switch for inducible adult angiogenesis. Antioxid. Redox Signal. 22 (2015), 1257–1272.
44. Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G., Bussolino, F., Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 18 (1999), 882–892.
45. Soriano, J.V., Liu, N., Gao, Y., Yao, Z.J., Ishibashi, T., Underhill, C., Burke, T.R. Jr., Bottaro, D.P., Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain bound antagonists. Mol. Cancer Ther. 3 (2004), 1289–1299.
46. Spearman, C., The proof and measurement of association between two things. Am. J. Psychol. 15 (1904), 72–101.
47. Staton, A.A., Giraldez, A.J., Use of target protector morpholinos to analyze the physiological roles of specific miRNA-mRNA pairs in vivo. Nat. Protoc. 6 (2011), 2035–2049.
48. Stelzer, G., Inger, A., Olender, T., Iny-Stein, T., Dalah, I., Harel, A., Safran, M., Lancet, D., GeneDecks: paralog hunting and gene-set distillation with GeneCards annotation. OMICS 13 (2009), 477–487.
49. Summerton, J.E., Morpholino, siRNA, and S-DNA compared: impact of structure and mechanism of action on off-target effects and sequence specificity. Curr. Top. Med. Chem. 7 (2007), 651–660.
50. Takashima, S., Kitakaze, M., Asakura, M., Asanuma, H., Sanada, S., Tashiro, F., Niwa, H., Miyazaki Ji, J., Hirota, S., Kitamura, Y., Kitsukawa, T., Fujisawa, H., Klagsbrun, M., Hori, M., Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 3657–3662.
51. Trapnell, C., Pachter, L., Salzberg, S.L., TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25 (2009), 1105–1111.
52. Trapnell, C., Williams, B.A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M.J., Salzberg, S.L., Wold, B.J., Pachter, L., Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28 (2010), 511–515.
53. Wang, C.H., Su, P.T., Du, X.Y., Kuo, M.W., Lin, C.Y., Yang, C.C., Chan, H.S., Chang, S.J., Kuo, C., Seo, K., Leung, L.L., Chuang, Y.J., Thrombospondin type I domain containing 7A (THSD7A) mediates endothelial cell migration and tube formation. J. Cell. Physiol. 222 (2010), 685–694.
54. Wong, N., Wang, X., miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 43 (2015), D146–152.
55. Yu, C., Sharma, A., Trane, A., Utokaparch, S., Leung, C., Bernatchez, P., Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo. Vasc. Pharmacol. 55 (2011), 26–33.
56. Zhang, B., Day, D.S., Ho, J.W., Song, L., Cao, J., Christodoulou, D., Seidman, J.G., Crawford, G.E., Park, P.J., Pu, W.T., A dynamic H3K27ac signature identifies VEGFA-stimulated endothelial enhancers and requires EP300 activity. Genome Res. 23 (2013), 917–927.
57. Zhang, B.T., Zhang, Z.Q., Xia, S.Y., Xing, C.S., Ci, X.P., Li, X., Zhao, R.R., Tian, S., Ma, G., Zhu, Z.M., Fu, L.Y., Dong, J.T., KLF5 activates MicroRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells. Mol. Cell. Biol. 33 (2013), 4919–4935.